JP Morgan maintains Overweight on Allient, raises price target to $95

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

JP Morgan analyst Tomohiko Sano maintained an Overweight rating on Allient (NASDAQ: ALNT) and raised the price target to $95 from $80.

powered bylight_fuzz_icon
45490675

*this image is generated using AI for illustrative purposes only.

JP Morgan analyst Tomohiko Sano has maintained an Overweight rating on Allient (NASDAQ: ALNT) and raised the price target to $95 from $80. The adjustment reflects a revised outlook on the stock's valuation potential.

Rating and Price Target

The brokerage's decision to upgrade the price target comes as it retains its positive stance on the company. The new target of $95 represents an increase from the prior level of $80.

Metric Value
Rating Overweight
Previous Price Target $80
New Price Target $95
Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific factors drove the revision in Allient's valuation potential?

How might Allient's recent performance influence other analysts' ratings?

What are the key risks that could prevent Allient from reaching the new $95 price target?

like16
dislike